Episode
AI in Drug Trials, Pfizer's Innovations, and NVIDIA's CoreWeave Partnership
- Podcast
- The AI News Daily Brief
- Published
- Jan 26, 2026
- Duration seconds
- 379
- Processing state
not_requested- Canonical source
- https://podcastai.com/daily-brief
Actions
POST https://stenobird.com/v1/public/podcasts/the-ai-news-daily-brief-7084833/episodes/ai-in-drug-trials-pfizer-s-innovations-and-nvidia-s-coreweave-partnership/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/the-ai-news-daily-brief-7084833/ai-in-drug-trials-pfizer-s-innovations-and-nvidia-s-coreweave-partnership.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
In this episode, Bob introduces the role of AI in drug development, particularly its impact on streamlining clinical trials. The discussion then shifts to Pfizer's recent innovations in AI, which have reportedly reduced the time to market for new drugs. Bob highlights Recursive's advancements in self-improving AI systems and their recent funding achievements. Attention is given to NVIDIA's collaboration and investment in CoreWeave's AI factories, which aim to bolster AI infrastructure. The episode concludes with closing remarks and an outlook on future developments in AI, emphasizing the importance of these advancements in shaping the industry.